Treatment of Uremic Pruritus With PA101B
Public ClinicalTrials.gov record NCT02696499. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Treatment of Uremic Pruritus With Inhaled PA101B in Patients With End-Stage Renal Disease Requiring Hemodialysis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a randomized, double blind, placebo-controlled, parallel-arm, multi-center, Phase 2, proof-of-concept efficacy and safety study in patients with end-stage renal disease requiring hemodialysis. The purpose of the study is to determine the efficacy and safety profile of PA101B delivered via eFlow high efficiency nebulizer in patients with uremic pruritus who are symptomatic despite using standard treatments.
Study identification
- NCT ID
- NCT02696499
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 70 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2016
- Primary completion
- Jul 31, 2016
- Completion
- Nov 30, 2016
- Last update posted
- Apr 19, 2018
2016
United States locations
- U.S. sites
- 13
- U.S. states
- 10
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Kidney Disease and Hypertension Center | Phoenix | Arizona | 85012 | — |
| US Renal Care | Pine Bluff | Arkansas | 71603 | — |
| Valley Renal Medical Group | Northridge | California | 91324 | — |
| North America Research Institute | San Dimas | California | 91773 | — |
| Pines Clinical Research, Inc. | Pembroke Pines | Florida | 33028 | — |
| Genesis Clinical Research | Tampa | Florida | 33614 | — |
| Boise Kidney and Hypertension Institute | Meridian | Idaho | 83642 | — |
| Fresenius Medical Care of Evergreen Park | Evergreen Park | Illinois | 60805 | — |
| Renal Medicine Associates | Albuquerque | New Mexico | 87109 | — |
| US Renal Care | Gallup | New Mexico | 87313 | — |
| Ridgewood Dialysis Center | Ridgewood | New York | 11385 | — |
| Brookview Hills Research Associates LLC | Winston-Salem | North Carolina | 27103 | — |
| Southeast Renal Research Institute | Chattanooga | Tennessee | 37408 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02696499, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 19, 2018 · Synced Sep 15, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02696499 live on ClinicalTrials.gov.